CORRECT: Gilead Sees 2010 Product Sales $7.6 Billion-$7.7 Billion
January 26 2010 - 6:42PM
Dow Jones News
Gilead Sciences Inc. (GILD) projects 2010 net product sales of
$7.6 billion to $7.7 billion, translating to growth of 17% to 19%
for the year.
Wall Street currently projects total revenue for the year of
$7.9 billion, which includes revenue from royalties, contracts and
other sources, according to Thomson Reuters. In 2009, The Foster
City, Calif., company, reported product sales of $6.47 billion and
revenue of $7.01 billion.
Earlier Tuesday, Gilead reported net income of $802.2 million,
or 87 cents a share, for the three months ended Dec. 31, up from
$560 million, or 59 cents a share, a year earlier. Excluding items,
earnings rose to 93 cents, exceeding analyst expectations of 85
cents a share, according to a survey from Thomson Reuters.
Revenue climbed 42% to $2.03 billion, also beating a Wall Street
projection of $1.93 billion.
-By Thomas Gryta, Dow Jones Newswires; 212-416-2169;
thomas.gryta@dowjones.com
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024